Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can you provide a timeline for apotex's ruxolitinib approval and launch in the us?Are there specific probiotics that complement lipitor's effectiveness?Do any studies directly link sapropterin to enhanced cognition?What side effects might combining lipitor and ginseng cause?Can cosentyx harm a fetus during pregnancy?
See the DrugPatentWatch profile for cosentyx
Can cosentyx be given after a live vaccine Cosentyx contains secukinumab, an interleukin-17 inhibitor that weakens immune function. Live vaccines use weakened viruses or bacteria and depend on a functional immune system to produce immunity. Giving Cosentyx after a live vaccine raises the risk that the weakened organism could replicate and cause infection in a suppressed immune system. How long should you wait after a live vaccine before starting Cosentyx Most guidelines recommend waiting at least four weeks after a live vaccine before beginning any biologic that suppresses immunity. The four-week period covers the usual incubation and replication time for live vaccines such as measles, mumps, rubella, varicella, or oral polio. Patients who already started Cosentyx before a live vaccine attempt should avoid them entirely unless the time elapsed is enough for the vaccine virus to clear. What happens if you receive a live vaccine while on Cosentyx Live vaccines are generally contraindicated during Cosentyx treatment. The product label warns against them because of the the risk of disseminated infection. Patients on Cosentyx should use non-live vaccines whenever possible. If a live vaccine is needed, the biologics must be held until the time point that the vaccine virus has cleared from the body. Are there exceptions or clinical data Clinical trials for Cosentyx excluded patients who received live vaccines within four weeks or patients who were on the drug and needed live vaccines. Real-world data on simultaneous or sequential use are limited. No specific studies show safe intervals shorter than the recommended four-week gap. Can biosimilars or competitors replace Cosentyx Biosimilars to secukinumab are still in development. Competitors such as Tremfya, Skyrizi, or Taltz offer similar WAI mechanisms but each has its own labeling around live vaccines. Patients who cannot wait four weeks after a live vaccine or need a more flexible schedule may discuss alternatives with their clinician.
Other Questions About Cosentyx :